Futura Medical plc
LSE: FUM.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Alex Duggan
- Employees
- 14
- Headquarters
- Guildford, United Kingdom
- IPO year
- 2003
- Market cap
- £2.1M
- Website
- https://www.futuramedical.com
Loading FUM…
Loading profile data…Frequently asked questions about FUM
What does Futura Medical plc (FUM.L) do?
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical d...
Where does FUM.L trade?
Futura Medical plc (FUM.L) trades on the London Stock Exchange.
What sector is FUM.L in?
Futura Medical plc (FUM.L) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Futura Medical plc?
Alex Duggan is the chief executive officer of Futura Medical plc (FUM.L).
Where is Futura Medical plc headquartered?
Futura Medical plc is headquartered in United Kingdom.
Does FUM.L pay a dividend?
Futura Medical plc (FUM.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did FUM.L go public?
Futura Medical plc (FUM.L) completed its initial public offering in 2003.